We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Localized Cardiac Cooling May Limit Infarct Damage

By HospiMedica International staff writers
Posted on 22 Jan 2018
A new study suggests that cooling sections of the heart during a heart attack, both prior to and following an angioplasty, could limit cardiac damage.

Researchers at Eindhoven University of Technology (TUE; The Netherlands), Catharina Hospital (Eindhoven, The Netherlands), and other institutions conducted a study in 10 patients suffering acute myocardial infarction (MI), whose primary percutaneous coronary intervention (PPCI) included selective sensor-monitored intracoronary hypothermia based on saline at room temperature administered distal to the culprit lesion through an inflated over-the-wire-balloon (OTWB), in order to cool the endangered myocardium for 10 minutes.

Once the OTWB was deflated, cooling continued with saline at 4°C for another 10 minutes during the reperfusion phase. More...
A sensor-tipped temperature wire in the distal coronary artery allowed titration of the infusion rate to achieve a desired coronary temperature of 6°C below body temperature, which was achieved within 27 seconds; routine PPCI was then performed. The results showed that in anterior wall MI, the protocol appeared safe, without serious hemodynamic or systemic side effects. In inferior wall MI, transient conduction abnormalities of short duration occurred. The study was published on December 8, 2017, in EuroIntervention.

“You can compare it with cooling the knee following a sports collision, for example, where an inflamed reaction occurs and the knee swells. To avoid this swelling, therefore, the muscles are often immediately cooled. We now apply the same principle to the heart muscle,” said lead author Luuk Otterspoor, MD, of TUE. “By cooling the part of the heart that is affected by a clogged or constricted coronary artery, there is less damage to the heart muscle after the constriction is opened up. We believe this can ultimately reduce the impact of the heart attack and damage to the heart by some 20-30 percent.”

During a PPCI angioplasty procedure, the constricted coronary artery should be opened up as quickly as possible. However, once blood begins to flow again, additional irreversible damage to the heart muscle is caused. This consequential damage, known as reperfusion injury, is the result of heart muscle cells swelling, which causes the capillaries to close. Animal models have shown that hypothermia reduces both reperfusion injury and infarct size, if started before PPCI reperfusion.

Related Links:
Eindhoven University of Technology
Catharina Hospital

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.